Amit B. Shah, CFO at Oncotelic Therapeutics, Inc. (OTLC), bought 20,000 shares at $0.05 ($1K) on 2026-06-22, disclosed to the SEC on 2026-06-22.
Open-market purchase of $1k OTLC by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.